BIOCON
Back to Income Statement
|
BIOCON Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹1,013 Cr | ₹1,023 Cr | ₹463 Cr | ₹648 Cr | ₹741 Cr |
What is the latest Consolidated Net Profit of BIOCON ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹1,013 Cr |
| Mar2024 | ₹1,023 Cr |
| Mar2023 | ₹463 Cr |
| Mar2022 | ₹648 Cr |
| Mar2021 | ₹741 Cr |
How is Consolidated Net Profit of BIOCON Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,013 Cr | -0.90 | |
| Mar2024 | ₹1,023 Cr | 120.99 | |
| Mar2023 | ₹463 Cr | -28.64 | |
| Mar2022 | ₹648 Cr | -12.44 | |
| Mar2021 | ₹741 Cr | - | |
Compare Consolidated Net Profit of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹62,858.5 Cr | 2.2% | 5.8% | 10.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,105.0 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,088.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| CIPLA | ₹107,120.0 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 2.2% |
5.8% |
10.4% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses